Replimune Group, Inc. — Director's Dealing 2020

Dec 10, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Replimune Group, Inc. (REPL)
CIK: 0001737953
Period of Report: 2020-12-07

Reporting Person: Dhingra Kapil (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-07	Common Stock	M	40000	$1.75	Acquired	40000	Direct
2020-12-07	Common Stock	S	24675	$45.09	Disposed	15325	Direct
2020-12-07	Common Stock	S	13523	$46.22	Disposed	1802	Direct
2020-12-07	Common Stock	S	1802	$47.04	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-12-07	Stock Option (right to buy)	$1.75	M	40000	Disposed	2026-01-21	Common Stock (40000)	Direct

Footnotes

F1: The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.84 to $45.82. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F2: The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.85 to $46.84. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F3: The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.85 to $47.21. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F4: The shares underlying this option vested on January 21, 2016.